LIVIVO - Search results -

Search results

Result 1 - 10 of total 175

Search options

Article ; Online: Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective.

Koopman, Miriam / Pinto, Carmine / Bodoky, György / Garcia-Carbonero, Rocio / Marti, Francisca Marti / Bachet, Jean-Baptiste

Future oncology (London, England)

2022 Volume 18, Issue 11, Page(s) 1313–1320

Abstract: The PROMETCO study is collecting real-world data on metastatic colorectal cancer (mCRC) patients with two progressions. This international, prospective, longitudinal, observational cohort study is collecting data on mCRC patients with two disease ... ...

Abstract	The PROMETCO study is collecting real-world data on metastatic colorectal cancer (mCRC) patients with two progressions. This international, prospective, longitudinal, observational cohort study is collecting data on mCRC patients with two disease progressions since diagnosis and receiving subsequent treatment. Objectives include overall survival, treatment patterns, effectiveness and safety and patient-reported outcomes using the EuroQol 5-level, 5-dimensional questionnaire, the Brief Fatigue Inventory and a modified version of the ACCEPTance by the Patients of their Treatment (ACCEPT
MeSH term(s)	Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cohort Studies ; Colorectal Neoplasms/drug therapy ; Continuity of Patient Care ; Humans ; Observational Studies as Topic ; Prospective Studies ; Retrospective Studies
Language	English
Publishing date	2022-01-19
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	2274956-1
ISSN	1744-8301 ; 1479-6694
ISSN (online)	1744-8301
ISSN	1479-6694
DOI	10.2217/fon-2021-1333
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6478: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Correction to: Chemotherapy in NEN: still has a role?

Espinosa-Olarte, Paula / La Salvia, Anna / Riesco-Martinez, Maria C / Anton-Pascual, Beatriz / Garcia-Carbonero, Rocio

Reviews in endocrine & metabolic disorders

2022 Volume 23, Issue 5, Page(s) 1103–1104

Language	English
Publishing date	2022-07-01
Publishing country	Germany
Document type	Published Erratum
ZDB-ID	2185718-0
ISSN	1573-2606 ; 1389-9155
ISSN (online)	1573-2606
ISSN	1389-9155
DOI	10.1007/s11154-022-09741-w
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 6069: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Gastric neuroendocrine neoplasms.

Lamberti, Giuseppe / Panzuto, Francesco / Pavel, Marianne / O'Toole, Dermot / Ambrosini, Valentina / Falconi, Massimo / Garcia-Carbonero, Rocio / Riechelmann, Rachel P / Rindi, Guido / Campana, Davide

Nature reviews. Disease primers

2024 Volume 10, Issue 1, Page(s) 25

Abstract: Gastric neuroendocrine neoplasms (gNENs) display peculiar site-specific features among all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs comprise gastric neuroendocrine carcinomas (gNECs) and gastric neuroendocrine ... ...

Abstract	Gastric neuroendocrine neoplasms (gNENs) display peculiar site-specific features among all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs comprise gastric neuroendocrine carcinomas (gNECs) and gastric neuroendocrine tumours (gNETs), the latter further classified into three types. Type I anatype II gNETs are gastrin-dependent and develop in chronic atrophic gastritis and as part of Zollinger-Ellison syndrome within a multiple endocrine neoplasia type 1 syndrome (MEN1), respectively. Type III or sporadic gNETs develop in the absence of hypergastrinaemia and in the context of a near-normal or inflamed gastric mucosa. gNECs can also develop in the context of variable atrophic, relatively normal or inflamed gastric mucosa. Each gNEN type has different clinical characteristics and requires a different multidisciplinary approach in expert dedicated centres. Type I gNETs are managed mainly by endoscopy or surgery, whereas the treatment of type II gNETs largely depends on the management of the concomitant MEN1. Type III gNETs may require both locoregional approaches and systemic treatments; NECs are often metastatic and therefore require systemic treatment. Specific data regarding the systemic treatment of gNENs are lacking and are derived from the treatment of intestinal NETs and NECs. An enhanced understanding of molecular and clinical pathophysiology is needed to improve the management and outcomes of patients' gNETs.
MeSH term(s)	Humans ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/epidemiology ; Neuroendocrine Tumors/therapy ; Zollinger-Ellison Syndrome/complications ; Gastritis, Atrophic/complications ; Gastritis, Atrophic/epidemiology ; Stomach Neoplasms/diagnosis ; Stomach Neoplasms/epidemiology ; Stomach Neoplasms/therapy ; Pancreatic Neoplasms
Language	English
Publishing date	2024-04-11
Publishing country	England
Document type	Journal Article ; Review
ISSN	2056-676X
ISSN (online)	2056-676X
DOI	10.1038/s41572-024-00508-y
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).

Castillón, Jaume Capdevila / Gordoa, Teresa Alonso / Bayonas, Alberto Carmona / Carretero, Ana Custodio / García-Carbonero, Rocío / Pulido, Enrique Grande / Fonseca, Paula Jiménez / Lete, Angela Lamarca / Huerta, Angel Segura / Plazas, Javier Gallego

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

2023 Volume 25, Issue 9, Page(s) 2692–2706

Abstract: Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, ...

Abstract	Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, along with steadfast improvements in therapy, has led to better prognosis over time for advanced gastrointestinal and pancreatic neuroendocrine tumors. The aim of this guideline is to update evidence-based recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification, and therapeutic options, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, are reviewed and discussed, and treatment algorithms to guide therapeutic decisions are provided.
MeSH term(s)	Humans ; Bronchial Neoplasms/diagnosis ; Bronchial Neoplasms/therapy ; Algorithms ; Carcinoma, Neuroendocrine ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/therapy
Language	English
Publishing date	2023-05-19
Publishing country	Italy
Document type	Journal Article
ZDB-ID	2397359-6
ISSN	1699-3055 ; 1699-048X
ISSN (online)	1699-3055
ISSN	1699-048X
DOI	10.1007/s12094-023-03205-6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 6644: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.

Garcia-Carbonero, Rocio

Cancer metastasis reviews

2014 Volume 33, Issue 1, Page(s) 343–344

MeSH term(s)	Combined Modality Therapy/trends ; Forecasting ; Humans ; Incidence ; Intestinal Neoplasms/epidemiology ; Intestinal Neoplasms/pathology ; Intestinal Neoplasms/therapy ; Neuroendocrine Tumors/epidemiology ; Neuroendocrine Tumors/pathology ; Neuroendocrine Tumors/therapy ; Pancreatic Neoplasms/epidemiology ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/therapy ; Stomach Neoplasms/epidemiology ; Stomach Neoplasms/pathology ; Stomach Neoplasms/therapy
Language	English
Publishing date	2014-03
Publishing country	Netherlands
Document type	Editorial
ZDB-ID	604857-2
ISSN	1573-7233 ; 0167-7659
ISSN (online)	1573-7233
ISSN	0167-7659
DOI	10.1007/s10555-013-9469-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1812: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives.

Riesco-Martinez, Maria C / Modrego, Andrea / Espinosa-Olarte, Paula / La Salvia, Anna / Garcia-Carbonero, Rocio

Current treatment options in oncology

2022 Volume 23, Issue 9, Page(s) 1320–1337

Abstract: Opinion statement: Colorectal cancer (CRC) is a major public health problem and the 2nd leading-cause of cancer-related death worldwide. Around 30% of patients present with metastatic disease and 50% of those with early disease will eventually relapse. ... ...

Abstract	Opinion statement: Colorectal cancer (CRC) is a major public health problem and the 2nd leading-cause of cancer-related death worldwide. Around 30% of patients present with metastatic disease and 50% of those with early disease will eventually relapse. The metastatic spread occurs mainly to the liver, which is the exclusive site in 30-40% of the cases. Surgery is the main curative option for liver recurrence, but only one out of five patients are eligible for resection. Moreover, even if surgery is feasible, recurrence rate is high, occurring in up to 75% of patients. Therefore, additional treatment to improve these disappointing outcomes has been sought. Adjuvant and perioperative chemotherapy aim to eradicate early micrometastatic disease, decreasing recurrence rates, and improving survival outcomes. Different chemotherapy regimens, mainly extrapolated from the adjuvant experience, have showed conflicting results, with improvements in disease free but not in overall survival. The addition of targeted therapies to chemotherapy has improved response rates and resectability when administered preoperatively, but did not have an impact on survival in the adjuvant setting. There is a need to critically synthetize the available evidence on perioperative and conversion therapy from the past years, and appraise areas of current research and potential future directions.
MeSH term(s)	Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/surgery ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/secondary ; Liver Neoplasms/surgery ; Neoplasm Recurrence, Local/drug therapy
Language	English
Publishing date	2022-08-18
Publishing country	United States
Document type	Journal Article ; Review ; Research Support, Non-U.S. Gov't
ZDB-ID	2057351-0
ISSN	1534-6277 ; 1527-2729
ISSN (online)	1534-6277
ISSN	1527-2729
DOI	10.1007/s11864-022-01008-5
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5523: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy.

Capdevila, Jaume / Grande, Enrique / García-Carbonero, Rocío / Simó, Marc / Del Olmo-García, Mª Isabel / Jiménez-Fonseca, Paula / Carmona-Bayonas, Alberto / Pubul, Virginia

The oncologist

2022 Volume 27, Issue 4, Page(s) e328–e339

Abstract: Background: The aim of this study was to provide a guidance for the management of neuroendocrine tumors (NETs) in clinical practice.: Material and methods: Nominal group and Delphi techniques were used. A steering committee of 8 experts reviewed the ... ...

Abstract	Background: The aim of this study was to provide a guidance for the management of neuroendocrine tumors (NETs) in clinical practice. Material and methods: Nominal group and Delphi techniques were used. A steering committee of 8 experts reviewed the current management of NETs, identified controversies and gaps, critically analyzed the available evidence, and formulated several guiding statements for clinicians. Subsequently, a panel of 26 experts, was selected to test agreement with the statements through 2 Delphi rounds. Items were scored on a 4-point Likert scale from 1 = totally agree to 4 = totally disagree. The agreement was considered if ≥75% of answers pertained to Categories 1 and 2 (consensus with the agreement) or Categories 3 and 4 (consensus with the disagreement). Results: Overall, 132 statements were proposed, which incorporated the following areas: (1) overarching principles; (2) progression and treatment response criteria; (3) advanced gastro-enteric NETs; (4) advanced pancreatic NETs; (5) advanced NETs in other locations; (6) re-treatment with radioligand therapy (RLT); (7) neoadjuvant therapy. After 2 Delphi rounds, only 4 statements lacked a clear consensus. RLT was not only recommended in the sequencing of different NETs but also as neoadjuvant treatment, while several indications for retreatment with RLT were also established. Conclusion: This document sought to pull together the experts' attitudes when dealing with different clinical scenarios of patients suffering from NETs, with RLT having a specific role where evidence-based data are limited.
MeSH term(s)	Consensus ; Humans ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/radiotherapy
Language	English
Publishing date	2022-04-05
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	1409038-7
ISSN	1549-490X ; 1083-7159
ISSN (online)	1549-490X
ISSN	1083-7159
DOI	10.1093/oncolo/oyab041
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4845: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 494: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.

Rinke, Anja / Ambrosini, Valentina / Dromain, Clarisse / Garcia-Carbonero, Rocio / Haji, Amyn / Koumarianou, Anna / van Dijkum, Els Nieveen / O'Toole, Dermot / Rindi, Guido / Scoazec, Jean-Yves / Ramage, John

Journal of neuroendocrinology

2023 Volume 35, Issue 6, Page(s) e13309

Abstract: This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format. Guided by key clinical questions practical advice on the diagnosis and management of ... ...

Abstract	This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format. Guided by key clinical questions practical advice on the diagnosis and management of neuroendocrine tumours (NET) of the caecum, colon, and rectum is provided. Although covered in one guidance paper colorectal NET comprises a heterogeneous group of neoplasms. The most common rectal NET are often small G1 tumours that can be treated by adequate endoscopic resection techniques. Evidence from prospective clinical trials on the treatment of metastatic colorectal NET is limited and discussion of patients in experienced multidisciplinary tumour boards strongly recommended. Neuroendocrine carcinomas (NEC) and mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) are discussed in a separate guidance paper.
MeSH term(s)	Humans ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/therapy ; Neuroendocrine Tumors/pathology ; Prospective Studies ; Colorectal Neoplasms/diagnosis ; Rectal Neoplasms/diagnosis ; Rectal Neoplasms/pathology ; Rectal Neoplasms/surgery ; Carcinoma, Neuroendocrine/diagnosis
Language	English
Publishing date	2023-06-22
Publishing country	United States
Document type	Journal Article
ZDB-ID	1007517-3
ISSN	1365-2826 ; 0953-8194
ISSN (online)	1365-2826
ISSN	0953-8194
DOI	10.1111/jne.13309
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2634: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Nab

Carrato, Alfredo / Pazo-Cid, Roberto / Macarulla, Teresa / Gallego, Javier / Jiménez-Fonseca, Paula / Rivera, Fernando / Cano, Maria Teresa / Rodriguez-Garrote, Mercedes / Pericay, Carles / Alés, Inmaculada / Layos, Laura / Graña, Begoña / Iranzo, Vega / Gallego, Inmaculada / Garcia-Carbonero, Rocio / de Mena, Inmaculada Ruiz / Guillén-Ponce, Carmen / Aranda, Enrique

NEJM evidence

2024 Volume 3, Issue 2, Page(s) EVIDoa2300144

Abstract: ... ...

Abstract	Nab
MeSH term(s)	Humans ; Albumins ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Deoxycytidine/adverse effects ; Gemcitabine ; Paclitaxel/adverse effects ; Pancreatic Neoplasms/drug therapy
Chemical Substances	130-nm albumin-bound paclitaxel ; Albumins ; Deoxycytidine (0W860991D6) ; Gemcitabine ; Paclitaxel (P88XT4IS4D)
Language	English
Publishing date	2024-01-23
Publishing country	United States
Document type	Clinical Trial, Phase II ; Journal Article ; Randomized Controlled Trial
ISSN	2766-5526
ISSN (online)	2766-5526
DOI	10.1056/EVIDoa2300144
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?

Garcia-Carbonero, Rocio / Anton-Pascual, Beatriz / Modrego, Andrea / Del Carmen Riesco-Martinez, Maria / Lens-Pardo, Alberto / Carretero-Puche, Carlos / Rubio-Cuesta, Beatriz / Soldevilla, Beatriz

Endocrine reviews

2023 Volume 44, Issue 4, Page(s) 724–736

Abstract: Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas are aggressive neoplasms of challenging clinical management. A small proportion of patients with early-stage disease may achieve long-term survival, but the majority of patients ... ...

Abstract	Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas are aggressive neoplasms of challenging clinical management. A small proportion of patients with early-stage disease may achieve long-term survival, but the majority of patients present with rapidly lethal metastatic disease. Current standard of care still follows the treatment paradigm of small cell lung cancer, a far more common G3 neuroendocrine neoplasm, although emerging molecular and clinical data increasingly question this approach. In this article, we will briefly summarize epidemiology and prognosis of gastroenteropancreatic neuroendocrine carcinomas to emphasize the very low incidence, aggressive nature, and orphan status of this tumor entity. We will also discuss the current pathological classification and its limitations, as well as recent data on their differential biological background compared with small cell lung cancer, and its potential implications for patients care. Then, we will review the standard of care of systemic therapy, basically focused on platinum-based cytotoxic chemotherapy, including some recent randomized trials providing evidence regarding efficacy of irinotecan vs etoposide platinum doublets. Finally, we will present a comprehensive overview of novel therapeutic strategies in current clinical development, including recently reported data on immunotherapy, tumor-agnostic therapies (microsatellite instability, high tumor mutational burden, NTRK and RET gene fusions, BRAF or KRAS inhibitors), and additional treatment strategies targeting other tumor vulnerabilities (ie, Notch pathway, novel targets for radioligand therapy), and provide some insights regarding unmet needs and future perspectives to improve patient's care and prognosis.
MeSH term(s)	Humans ; Small Cell Lung Carcinoma ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/genetics ; Carcinoma, Neuroendocrine/metabolism ; Carcinoma, Neuroendocrine/pathology ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/drug therapy ; Lung Neoplasms
Language	English
Publishing date	2023-03-07
Publishing country	United States
Document type	Review ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	603096-8
ISSN	1945-7189 ; 0163-769X
ISSN (online)	1945-7189
ISSN	0163-769X
DOI	10.1210/endrev/bnad006
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1562: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito